Pharmafile Logo

Health literacy in the time of COVID-19

In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health literacy has never been more important.

COVID-19 has prompted an interest in microbiology, immunology, epidemiology, and public health never seen on this scale before. However, it has also further polarized the population when it comes to public health measures such as vaccines and face masks.

In a 2020 survey conducted in a nationally representative sample of 3,133 adults in the USA, 20% of respondents intended to decline a vaccine once available. The most important determinants of COVID-19 vaccine hesitancy were distrust of the vaccine safety and general vaccine avoidance, as implied by not having had a flu shot in the last two years. Further, the authors noted that inconsistent risk messages from public health experts and elected officials may reduce vaccine uptake. Likewise, a survey conducted in Portugal in late 2020 identified having no intention of taking the flu vaccine and perception of the information provided as inconsistent and contradictory as two key factors associated with COVID-19 vaccine hesitance. This indicates that clear, easy-to-understand, and consistent messaging is key to improving health literacy and fighting misinformation.

In addition to vaccine hesitancy, Vergara et al. (2021) highlighted that two even bigger challenges that public health authorities will be facing in the new normal are the “postmodern condition of information blast” and “the objectivity of the held truth.” We are looking at a brand-new type of epidemic–an “infodemic”–where fake news and false scientific claims are progressively spread.

However, identifying the problem is only the first step. The challenge is coming up with a solution.

Read the full article here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Clinical Trial Protocol Conceptualization: A Customer Story

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...